SignificantEconomyAxios·Axios
Medicare weight-loss drug coverage could overwhelm doctors

President Trump struck a deal with Eli Lilly and Novo Nordisk for reduced prices on diabetes and anti-obesity drugs in exchange for wider patient access. Medicare's new program offering weight-loss drugs for $50 monthly is expected to create significant demand and strain on healthcare providers.
Impact Score
6/10
Monday, June 15, 2026 at 05:30 AM EDT
Read original source →